Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C28H28N2O3 |
| Molecular Weight | 440.5335 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)OCC1=CC2=C(C=C1)N(CCCO)C3=C4CC5=CC=CC=C5C4=C6C(=O)NCC6=C23
InChI
InChIKey=MLIFNJABMANKEU-UHFFFAOYSA-N
InChI=1S/C28H28N2O3/c1-16(2)33-15-17-8-9-23-20(12-17)25-22-14-29-28(32)26(22)24-19-7-4-3-6-18(19)13-21(24)27(25)30(23)10-5-11-31/h3-4,6-9,12,16,31H,5,10-11,13-15H2,1-2H3,(H,29,32)
Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Code | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
10275001
Created by
admin on Sat Dec 16 11:17:37 GMT 2023 , Edited by admin on Sat Dec 16 11:17:37 GMT 2023
|
PRIMARY | |||
|
CEP-5214
Created by
admin on Sat Dec 16 11:17:37 GMT 2023 , Edited by admin on Sat Dec 16 11:17:37 GMT 2023
|
PRIMARY | CEP-5214 is a potent, low-nanomolar pan inhibitor of human VEGF-R tyrosine kinases, displaying IC(50) values of 16, 8, and 4 nM for VEGF-R1/FLT-1, VEGF-R2/KDR, and VEGF-R3/FLT-4, respectively, with cellular activity equivalent to the isolated enzyme activity. Compound 21 exhibited good selectivity against numerous tyrosine and serine/threonine kinases including PKC, Tie2, TrkA, CDK1, p38, JNK, and IRK. | ||
|
A3X38AF5BQ
Created by
admin on Sat Dec 16 11:17:37 GMT 2023 , Edited by admin on Sat Dec 16 11:17:37 GMT 2023
|
PRIMARY | |||
|
402857-39-0
Created by
admin on Sat Dec 16 11:17:37 GMT 2023 , Edited by admin on Sat Dec 16 11:17:37 GMT 2023
|
PRIMARY | |||
|
CHEMBL150894
Created by
admin on Sat Dec 16 11:17:37 GMT 2023 , Edited by admin on Sat Dec 16 11:17:37 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
